FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/11/059574 [Registered on: 06/11/2023] Trial Registered Prospectively
Last Modified On: 08/11/2023
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   An artificial intelligence based study to evaluate the association between Covid infection or vaccination on heart diseases 
Scientific Title of Study   Influence of Covid-19 infection and vaccination on coronary artery disease and its risk factors: An artificial intelligence based study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Raghavendra U 
Designation  Associate Professor 
Affiliation  Manipal Academy of Higher Education 
Address  Department of Instrumentation and Control Engineering Manipal Institute of technology Manipal Academy of Higher Education

Udupi
KARNATAKA
576104
India 
Phone  9008052848  
Fax    
Email  raghavendra.u@manipal.edu  
 
Details of Contact Person
Scientific Query
 
Name  Dr Raghavendra U 
Designation  Associate Professor 
Affiliation  Manipal Academy of Higher Education 
Address  Department of Instrumentation and Control Engineering Manipal Institute of technology Manipal Academy of Higher Education

Udupi
KARNATAKA
576104
India 
Phone  9008052848  
Fax    
Email  raghavendra.u@manipal.edu  
 
Details of Contact Person
Public Query
 
Name  Dr Raghavendra U 
Designation  Associate Professor 
Affiliation  Manipal Academy of Higher Education 
Address  Department of Instrumentation and Control Engineering Manipal Institute of technology Manipal Academy of Higher Education

Udupi
KARNATAKA
576104
India 
Phone  9008052848  
Fax    
Email  raghavendra.u@manipal.edu  
 
Source of Monetary or Material Support  
Room No 36 3rd Floor OPD Block Department of Cardiology Kasturba Medical College Manipal Academy of Higher Education 
 
Primary Sponsor  
Name  Dr Raghavendra U 
Address  Department of ICE Manipal Institute of Technology Manipal Academy of Higher Education 
Type of Sponsor  Other [SELF] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Raghavendra U  Kasturba Hospital  Room No 36 3rd Floor OPD Bolck Department of Cardiology Kasturba hospital Manipal
Udupi
KARNATAKA 
9008052848

raghavendra.u@manipal.edu 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Kasturba Medical College and Kasturba Hopsital Institutional ethics committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: I70||Atherosclerosis,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  NIL  NIL 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  Patients of age 18 years and above (have been vaccinated or not)
Participants who are undergoing coronary angiogram at the Department of Cardiology Kasturba Hospital Manipal
Able to read write and converse in English/Kannada
 
 
ExclusionCriteria 
Details  Participants who are not willing to give consent
Patients with congenital heart disease
Patients with known genetic diseases and related cardiomyopathies
Patients with rheumatic heart diseases
Patients with major psychiatric disorders, dementia or delirium.
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
The proportion of Coronary Artery Disease
Risk factors for Coronary artery disease
Determinants of Coronary artery disease 
At the recruitment 
 
Secondary Outcome  
Outcome  TimePoints 
Treadmil stress test findings
CT angio results
Left ventrcular function 
At the recruitment 
 
Target Sample Size   Total Sample Size="1800"
Sample Size from India="1800" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   13/11/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Open to Recruitment 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

After IEC clearance and CTRI registration, this prospective observational study will be conducted. Patients who are undergoing coronary angiogram and who meet the inclusion criteria will be included in this study. Informed consent will be obtained prior to the recruitment. Brief details of the patient’s demographic and clinical history are obtained. This includes age, gender, weight, height, and comorbidity history related to cardiovascular diseases. Further, a brief history is taken regarding COVID 19- infection and vaccination details. COVID-19 infection is confirmed based on verbal communication however, the severity of COVID-19 infection will be assessed based on documented evidence if any. If the participant does not know the vaccination details himself/herself, we intend to contact his/her relative personally, if not, telephonically to gather the information on COVID 19- infection and vaccination status. Blood test reports such as complete lipid profile, Hb, NT-Pro BNP, Troponin T, D-Dimer, CRP values are documented if present. Further, a few parameters are obtained from ECG, Treadmill stress test (TMT), Chest X-Ray, Echocardiogram, and CT-coronary angiogram if performed in them. These parameters include ST-T changes in ECG, test results of TMT, Ejection fraction and abnormal findings of the echocardiographic test, Heart failure changes in chest X-Ray, and Coronary calcium score from CT. All the parameters and data that are extracted are drawn from the tests that are routinely performed among patients undergoing coronary angiogram tests as a part of standard care. Meanwhile, Gensini score and Syntax scores are used in the severity assessment of the coronary artery using coronary angiogram. In addition, blood test parameters, ECG, Echo, TMT, CT and CAG parameters during COVID infection or before the COVID-19 era are also documented if available. A copy of 12 lead ECGs, Chest X-Ray images, Apical 4 chamber images from stored Echocardiographic data, and coronary angiogram recording will be taken for the creation of an automated diagnostic model.

 
Close